How long does Trelegy stay in your system after you stop taking it?
Trelegy Ellipta contains three medicines: an inhaled corticosteroid (fluticasone furoate), an inhaled long-acting beta agonist (vilanterol), and an antimuscarinic (umeclidinium). Because they differ in absorption and how the body clears them, there is no single “one size fits all” time window for everyone.
In general, the medicines clear from the body over days, but their effects in the airways can last longer than the drugs themselves because they reduce airway inflammation and help keep airways open after dosing has ended.
What are the typical timelines for each component?
Trelegy’s components have different half-lives (the time it takes for the amount of drug in the body to drop by about half). With inhaled medicines, the exact timing can vary by person and by how long you’ve been taking the product.
- Umeclidinium (antimuscarinic) and vilanterol (LABA) are both designed for once-daily dosing and generally clear over roughly 1–2 days in many people (based on pharmacology/half-life ranges).
- Fluticasone furoate (inhaled steroid) tends to persist longer in the body than the other two and is more likely to have measurable effects over several days after stopping, even if you stop using the inhaler.
A practical way people think about this is: you may be “fully off” the medicine’s immediate physiologic effects within a few days, but lingering drug activity or residual effects can take longer.
Will it show up on a drug test?
It depends on the type of drug test. Standard workplace drug tests usually target common illicit drugs and opioids and typically do not screen for inhaled asthma/COPD medicines like fluticasone, umeclidinium, or vilanterol.
If a specific test panel includes prescription or “performance-enhancing” compounds, results can vary by lab and assay type. For an accurate answer, you’d need to know the exact test (and whether it includes these specific drugs).
Does your dose schedule or kidney/liver function change how long it stays?
Yes. Your clearance can change with:
- Kidney or liver function (especially for components processed through metabolic pathways).
- How long you’ve been using Trelegy (steady-state use can mean drug levels reach a consistent daily pattern).
- Other medicines that affect drug metabolism.
- Severity of COPD/asthma and breathing pattern, which can affect how much drug deposits in the lungs versus what gets swallowed and absorbed through the GI tract.
Can you stop Trelegy abruptly, or do you need to taper?
This depends on why you’re taking it (COPD vs asthma) and your overall treatment plan. For asthma, inhaled steroids generally should not be stopped without clinician guidance, since airway inflammation can worsen. For COPD, some clinicians may change therapy without tapering, but you should not adjust or stop Trelegy without medical advice.
If you tell me whether you’re using Trelegy for COPD or asthma and the date of your last dose, I can give a more tailored time window for when it’s likely to be “mostly out” versus when airway effects may still be present.